The differential diagnostic value and clinical significance of serum HE4 in ovarian disease with elevated CA125

被引：0
|
作者：
Weishan Li
Danbo Wang
机构：
[1] Cancer Hospital of China Medical University,
来源：
Archives of Gynecology and Obstetrics | 2020年 / 301卷
关键词：
HE4; CA125; Ovarian disease; Differential diagnosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1219 / 1225
页数：6
相关论文
共 50 条
  • [41] HE4 and CA125 as a diagnostic test in ovarian cancer: prospective validation of the Risk of Ovarian Malignancy Algorithm
    Van Gorp, T.
    Cadron, I.
    Despierre, E.
    Daemen, A.
    Leunen, K.
    Amant, F.
    Timmerman, D.
    De Moor, B.
    Vergote, I.
    BRITISH JOURNAL OF CANCER, 2011, 104 (05) : 863 - 870
  • [42] Correlation analysis and clinical significance of CA125, HE4, DDI, and FDP in type II epithelial ovarian cancer
    Qiao, Li
    Chen, Xinhua
    Xi, Xuxia
    Chen, Xueqin
    Zhang, Pengpeng
    Dong, Hua
    Wu, Xiaohua
    Chen, Xiaojun
    MEDICINE, 2020, 99 (49) : E23329
  • [43] HE4 and CA125 as a diagnostic test in ovarian cancer: prospective validation of the Risk of Ovarian Malignancy Algorithm
    T Van Gorp
    I Cadron
    E Despierre
    A Daemen
    K Leunen
    F Amant
    D Timmerman
    B De Moor
    I Vergote
    British Journal of Cancer, 2011, 104 : 863 - 870
  • [44] Predictive value of serum HE4 and CA125 concentrations for lymphatic metastasis of endometrial cancer
    Wang, Yingmei
    Han, Cha
    Teng, Fei
    Bai, Zhaoyi
    Tian, Wenyan
    Xue, Fengxia
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2017, 136 (01) : 58 - 63
  • [45] Clinical application of HE4 and CA125 in ovarian cancer Type I and Type II detection and differential diagnosis
    Gasiorowska, Emilia
    Michalak, Marcin
    Warchol, Wojciech
    Lemanska, Agnieszka
    Jasinski, Piotr
    Spaczynski, Marek
    Nowak-Markwitz, Ewa
    GINEKOLOGIA POLSKA, 2015, 86 (02) : 88 - 93
  • [46] Significance of HE4 estimation in comparison with CA125 in diagnosis of ovarian cancer and assessment of treatment response
    Elham O Hamed
    Hydi Ahmed
    Osama B Sedeek
    Abeer M Mohammed
    Ali A Abd-Alla
    Hazem M Abdel Ghaffar
    Diagnostic Pathology, 8
  • [47] Clinical analysis of four serum tumor markers in 458 patients with ovarian tumors: diagnostic value of the combined use of HE4, CA125, CA19-9, and CEA in ovarian tumors
    Chen, Fawen
    Shen, Jing
    Wang, Jianwei
    Cai, Pengwei
    Huang, Yi
    CANCER MANAGEMENT AND RESEARCH, 2018, 10 : 1313 - 1318
  • [48] Measuring HE4 alongside CA125 for ovarian cancer diagnosis: A pilot clinical study
    Crawford, S. Michael
    Evans, Colin
    Shaw, Alison
    Barr, Chloe E.
    Crosbie, Emma J.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2024,
  • [49] No benefit from combining HE4 and CA125 as ovarian tumor markers in a clinical setting
    Jacob, Francis
    Meier, Mara
    Caduff, Rosmarie
    Goldstein, Darlene
    Pochechueva, Tatiana
    Hacker, Neville
    Fink, Daniel
    Heinzelmann-Schwarz, Viola
    GYNECOLOGIC ONCOLOGY, 2011, 121 (03) : 487 - 491
  • [50] Evaluation of Serum HE4 in Ovarian Tumors, Its Comparison with Serum CA125 and Correlation with Histological Subtypes
    Khati S.
    Jaiswal R.
    Singh N.
    Indian Journal of Gynecologic Oncology, 2018, 16 (4)
12345